Clinical trial | Country-City | Year | Patient age | Type of examination |
---|---|---|---|---|
(years) | ||||
England, Wales, Scotland | 1991 | 39-41 | Mammography: 2 views, and then 1 view every 12 months | |
Goteborg, Sweden | 1982 | 39-59 | Mammography: 2 views, and then 1 view every 18 months, 4 to 5 screening rounds | |
Malmo, Sweden | MMST 1: 1976 | MMST 1: 44–68 | Mammography: 2 views (first 2 rounds) and then 1 view every 18 to 24 months, 5 screening rounds | |
MMST 2: 1978 | MMST 2: 45-50 | |||
Stockholm, Sweden | 1981 | 40-64 | Mammography: 1 view every 24 months, 2 screening rounds | |
15 centers, Canada | 1980 | NBSS-1: 40–49 | NBSS-1: | |
Mammography: 2 views then 1 clinical examination every 12 months | ||||
NBSS-2:50-59 | S: Self-examination training | |||
C: Self-examination training + annual history taking | ||||
NBSS-2: | ||||
S: Mammography: 2 views then1 clinical examination every 12 months | ||||
C: Self-examination training and 1 clinical examination every 12 months | ||||
Edinburgh [34] | Edinburgh, Scotland | 1978 | 45-64 | S: Mammography : 2 views and then 1 view every 24 months |
+ Clinical examination every 12 months | ||||
8 screening rounds | ||||
C: Self-examination | ||||
Kopparberg, Ostergotland, Sweden | 1977 Kopparberg | 40-74 | Mammography: 1 view | |
1978 Ostergoland | - every 24 months for women aged 40 to 49 | |||
-every 33 months for women over 49 | ||||
2 screening rounds | ||||
New York, USA | 1963 | 40-64 | Mammography: 2 views and then 1 view every 12 months | |
+ Clinical examination every 12 months | ||||
+ History taking only during the 1st round | ||||
4 screening rounds |